Published in Law and Health Weekly, January 12th, 2004
He replaces in this position Rudolf Reiter who has left the board effective December 2003. Schulz-Knappe is one of the founders of BioVisioN AG and had been CEO of the company until April 2003.
Rainer Voegeli has joined the management team of the company as chief business officer (CBO) and head of business development and marketing. Voegeli has gained his management experience at various positions over several years in the pharmaceutical industry (ASTA Medica AG) as well as in the biotech industry...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.